---
title: "REF: Long-Term Follow Up"
slug: "ref-long-term-follow-up"
updated: 2025-01-28T15:38:39Z
published: 2025-01-28T15:38:39Z
canonical: "bgtcplaybook.document360.io/ref-long-term-follow-up"
---

> ## Documentation Index
> Fetch the complete documentation index at: https://bgtcplaybook.document360.io/llms.txt
> Use this file to discover all available pages before exploring further.

# REF: Long-Term Follow Up

1. CHMP. (2010, May). Guideline on follow-up of patients administered with gene therapy medicinal products. Retrieved from EMA: [https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-follow-patients-administered-gene-therapy-medicinal-products_en.pdf](https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-follow-patients-administered-gene-therapy-medicinal-products_en.pdf)
2. FDA. (2020, January). Long Term Follow-up after Administration of Human Gene Therapy Products. Retrieved from [https://www.fda.gov/media/113768/download](http:// https://www.fda.gov/media/113768/download)
3. Monica R. Shah, E. P. (November 1, 2021). Long-term Follow-up for Gene Therapies- Innovative, patient-centered approaches - Insight Brief. IQVIA Biotech - Insight brief, 11. Retrieved from: [https://www.iqvia.com/~/media/Biotech/PDFS/LI/Long-term-follow-up-for-gene-therapies](https://www.iqvia.com/~/media/Biotech/PDFS/LI/Long-term-follow-up-for-gene-therapies)
4. Novartis Gene Therapies, I. (2021). What’s next for gene therapy? Here are five trends to watch. Retrieved from Novartis - Sponsored Insight: [https://www.statnews.com/sponsor/2021/06/10/whats-next-for-gene-therapy/](https://www.statnews.com/sponsor/2021/06/10/whats-next-for-gene-therapy/)